The risk of cardiovascular events is increased in people with glucocorticoid-induced lipodystrophy

Jun-13

Cardiovascular Endocrinology Pharmacoepidemiology

AUTHORS : Dr Laurence Fardet, Henri Mondor Hospital, 51 Avenue du Maréchal de Lattre de Tassigny, 94010 Créteil, France – E-mail: laurence.fardet@aphp.fr

JOURNAL : Annals of the Rheumatic Diseases

REFERENCE: 71(S3):630-631

DOI : 10.1136/annrheumdis-2012-eular.3414

Read more

More publications

Apr-25

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Diabetes Pharmacoepidemiology

Read more

Feb-25

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Pharmacoepidemiology Rheumatology

Read more

Feb-25

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study

Pharmacoepidemiology Rheumatology

Read more